Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS101 in semantic variant primary progressive aphasia (svPPA)
NCT07154485Phase 2Not yet recruiting
- Start
- Oct 2025
- Primary completion
- Aug 2027
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of NS101 in semantic variant primary progressive aphasia (svPPA). Planned start Oct 2025; status: not yet recruiting.
02
Drugs
NS101
03
Conditions
semantic variant primary progressive aphasia (svPPA)
Beyond the preview
Go deeper on NCT07154485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07154485.